Preclinical studies of NOS inhibitor T1059 vasopressor activity on the models of acute hemorrhagic shock in rats and dogs

The development of new effective and safe vasopressors is one of the ways to increase the effectiveness of the treatment of hypotensive disorders, the severe forms of which remain a common cause of death in all countries of the world. Previously, we synthesized the original compound T1059, a selecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Filimonova, Marina, Shevchenko, Ljudmila, Makarchuk, Victoria, Saburova, Alina, Shegay, Petr, Kaprin, Andrey, Ivanov, Sergey, Filimonov, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561252/
https://www.ncbi.nlm.nih.gov/pubmed/36249787
http://dx.doi.org/10.3389/fphar.2022.995272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561252/
https://www.ncbi.nlm.nih.gov/pubmed/36249787
http://dx.doi.org/10.3389/fphar.2022.995272

Ejemplares similares